# Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults

> **NCT00218114** · PHASE3 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 25 (actual)

## Conditions studied

- Attention Deficit and Disruptive Behavior Disorders
- Marijuana Abuse

## Interventions

- **DRUG:** Divalproex Sodium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00218114
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2005-02-18
- **Final completion:** 2005-02-18
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218114, "Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00218114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*